{"organizations": [], "uuid": "bba3cf616094f40d90fb1189ef5335e75030b3cd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180425.html", "section_title": "Archive News &amp; Video for Wednesday, 25 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mylan-adds-to-growing-womens-healt/brief-mylan-adds-to-growing-womens-healthcare-portfolio-with-launch-of-generic-for-oral-contraceptive-yaz-idUSASC09XA8", "country": "US", "domain_rank": 408, "title": "BRIEF-Mylan Adds To Growing Women's Healthcare Portfolio With Launch Of Generic For Oral Contraceptive Yaz", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-25T19:38:00.000+03:00", "replies_count": 0, "uuid": "bba3cf616094f40d90fb1189ef5335e75030b3cd"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mylan-adds-to-growing-womens-healt/brief-mylan-adds-to-growing-womens-healthcare-portfolio-with-launch-of-generic-for-oral-contraceptive-yaz-idUSASC09XA8", "ord_in_thread": 0, "title": "BRIEF-Mylan Adds To Growing Women's Healthcare Portfolio With Launch Of Generic For Oral Contraceptive Yaz", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "mylan", "sentiment": "negative"}, {"name": "mylan nv", "sentiment": "negative"}, {"name": "bayer", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Mylan NV:\n* MYLAN ADDS TO GROWING WOMEN’S HEALTHCARE PORTFOLIO WITH LAUNCH OF GENERIC FOR ORAL CONTRACEPTIVE YAZ®\n* MYLAN NV - U.S. LAUNCH OF DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP, 3 MG/0.02 MG, A GENERIC VERSION OF BAYER’S YAZ TABLETS Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-25T19:38:00.000+03:00", "crawled": "2018-04-26T20:53:01.050+03:00", "highlightTitle": ""}